{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-066061","form_type":"8-K","ticker":"CRMD","cik":"0001410098","company_name":"CorMedix Inc.","filed_at":"2026-06-08T12:45:18+00:00","discovered_at":"2026-06-08T12:50:00.380664+00:00","generated_at":"2026-06-08T12:50:37.339815+00:00","sec_items":["7.01","9.01"],"event_type":"litigation","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Federal Circuit upholds CorMedix's MINOCIN patents; Nexus generic barred from market","bullets":["Federal Circuit affirmed district court: Nexus generic minocycline infringes two CorMedix patents, invalidity rejected.","Permanent injunction upheld barring Nexus from marketing generic before patent expiration.","Patents are FDA Orange Book listed covering MINOCIN for Injection, used for serious infections.","CEO Joseph Todisco: ruling validates strength of MINOCIN IP portfolio and protects innovation."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-066061","json":"https://secwatch.observer/filing/0001213900-26-066061.json","markdown":"https://secwatch.observer/filing/0001213900-26-066061.md","text":"https://secwatch.observer/filing/0001213900-26-066061.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026066061/0001213900-26-066061-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1410098/000121390026066061/ea0293895-8k_cormedix.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T12:50:37.339815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}